Rafael Santana Davila MD MD

Head & Neck Cancer, Thoracic Cancer

Associate Professor. Washington State University Swedish/Providence Cancer Institute

1221 Madison StFl 2Seattle, WA 98104
Phone+1 206-386-2323
Fax+1 206-215-6165

Dr. Santana Davila is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Santana Davila's full profile Already have an account?

Summary

Dr. Rafael Santana Davila is an oncologist in Seattle, WA and is affiliated with multiple hospitals in the area, including Seattle Cancer Care Alliance and UW Medicine/University of Washington Medical Center. He received his medical degree from Universidad Anahuac School of Medicine and has been in practice 16 years. He specializes in thoracic cancer and is experienced in pancreatic cancer, amyloidosis, hematologic oncology, myelodysplasia, and myelofibrosis.

Education & Training

Medical College of WisconsinMSc, Clinical and Translational Science, 2010
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 2006 - 2010
Mayo Clinic College of MedicineHematology and Oncology, 2006 - 2010
University of MinnesotaResidency, Internal Medicine, 2003 - 2006
Universidad Anahuac School of MedicineClass of 2001

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

WA State Medical License 2014 - 2027
AK State Medical License 2023 - 2026
FL State Medical License 2018 - 2020
WI State Medical License 2010 - 2015
MN State Medical License 2006 - 2011
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2013-2014
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Small Grant Program Award Mayo Clinic Department of Oncology, 2009

Clinical Trials

OT-101 in Combination With Atezolizumab for the Treatment of Metastatic or Recurrent Non-Small Cell Lung Cancer Start of enrollment: 2023 Dec 01
WITHDRAWN
PHASE2
Roles: Contact, Principal Investigator

Publications & Presentations

PubMed

Mature Outcomes and Patterns of Failure in the Phase II FLARE-RT Trial of Biological Image-Guided and Risk-Adaptive Chemoradiation for Unresectable NSCLC.
Jing Zeng, Sunan Cui, Daniel S Hippe, Jie Fu, Faisal Yaseen
Clinical Cancer Research. 2026-08-14
Dual PD-1 and CTLA4 Immune Checkpoint Blockade and Hypofractionated Radiation in Patients With Advanced Salivary Gland Cancers.
Cristina P Rodriguez, Qian Vicky Wu, Kevin Ng, Jenna Voutsinas, Jonathan R Fromm
Head & Neck. 2025-09-01
Napsin A-specific T-cell clonotypes are associated with improved clinical outcomes in patients receiving checkpoint immunotherapy for metastatic non-small cell lung ca...
Natalie J Miller, Christina Baik, Joel W Neal, Fangdi Sun, Rafael Santana-Davila
Journal for Immunotherapy of Cancer. 2025-07-15

Journal Articles

Evaluation and management of elderly patients with lung cancer.
Gore E, Movsas B, Santana-Davila R, Langer C, Semin Radiat Oncol, 1/1/2012
Treatment options for patients with triple-negative breast cancer.
Santana-Davila, R. & Perez, E.A., J Hematol Oncol, 1/1/2010
Capecitabine and temozolomide: design, implementation, and preliminary outcomes from a pilot project to ensure safe prescribing of oral chemotherapy.
Jatoi, A., Smith EL, Gunderson, HD, Hartgers, ML, Looker SA, Santana-Davila R, McWilliams RR, J Oncol Pract, 1/1/2010

Lectures

Clinicopathological characteristics of subsequent breast cancers in patients with benign breast disease.
45th Annual Meeting of the American Society of Clinical Oncology, Orlando, FL - 1/1/2009
Deletion 5q in Acute Myeloid Leukemia (AML): a Clinicopathological Description of 79 Cases From a Single Institution.
50th Annual Meeting of the American Society of Hematology, San Francisco, CA - 1/1/2008
Deletion 5q in WHO- Defined Myeloproliferative Neoplasms: A Clinicopathological Description
49th Annual Meeting of the American Society of Hematology, Atlanta, GA - 1/1/2007